Skip to main content

Table 1 Demographic and clinical variables

From: Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth

Variables (N = 120)

Values (mean ± SD or N)

Gestational age at birth (weeks, preterm/full-term, mean ± SD)

28.83 ± 3.37/39.72 ± 1

Gestational age at birth (23–25/26–27/28–29/30–31/32–33/34–35 weeks/full-term, N)

25/22/11/11/18/8/25

Birth Weight (Kg, preterm/full-term, mean ± SD)

1.29 ± 0.57/3.6 ± 0.45

Sex (male/female, N)

59/61

Race (Caucasian/AA/Asian/Other, N)a

76/29/1/14

Ethnicity (Hispanic or Latino Y/N/unnkown, N)

13/103/4

Delivery method (C-section/vaginal, N)

60/60

Necrotizing enterocolitis diagnosis (medical, surgical, N)b

11

Received antimicrobials (any, ≥ 7 days, N)c

82 / 63

Received diuretics (any, N)c

54

Received postnatal corticosteroids (any, N)c

22

Received proton pump inhibitors (any, N)c

7

Received H2 receptor antagonist (any, N)c

13

Received motility agents (any, N)c

24

  1. aOther race includes those unknown
  2. bNecrotizing enterocolitis diagnosis (medical, surgical) diagnosis for one baby is unknown because of early withdrawal from study
  3. c Medication received within 1 week prior to microbiome sample collection. Sample collection occurred approximately weekly throughout the majority of the hospitalization as clinically permitted. If the interval between samples was greater than 7 days apart, then short portions of the hospital stay are not covered by this analysis. Therefore, subjects who had the respective medication, but not within 1 week prior to sample collection, are not counted in this summary table